Subscribe to MDT Magazine News

Microbix Biosystems CEO sells 250,700 shares, reinvests proceeds in subsidiary

January 6, 2011 6:45 am | by The Associated Press | Comments

Microbix Biosystems Inc. (TSX:MBX) CEO William J. Gastle sells 250,700 shares in the company, reinvests proceeds of just over $100,00 in Microbix majority-owned subsidiary Crucible International Biotechnologies Corp..

Skilled Healthcare boosts 2010 estimate

January 6, 2011 6:45 am | by The Associated Press | Comments

Nursing home operator Skilled Healthcare Group Inc. on Thursday boosted its full-year profit estimate, citing better-than-expected results from the hospice and home health care units.The company now expects adjusted earnings between $1.01 and $1.04 per share on revenue between $816 million and...

Graphene grains make atomic patchwork quilts

January 6, 2011 6:35 am | by I-Micronews | Comments

A quick look at new Cornell research hints at colorful patchwork quilts, but they are actually pictures of graphene -- one atom-thick sheets of carbon stitched together at tilted interfaces.


Avedro's laser surgery tech attracts $6.3M

January 6, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Laser vision technology startup Avedro Inc. has added almost $1.7 million to a securities offering that brought the company $4.6 million in July, according to an amended regulatory filing.

DK Sinopharma, Inc. Reviews its Honors of the Year 2010

January 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

XI'AN, China, Jan. 6, 2011 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC Bulletin Board: DKSP ) ("DK Sinopharma" or the "Company") reviewed the honors received in the year of 2010 to celebrate the achievements and successes over the past year. In February 2010, the Company won...


What About Us? The State of Women's Sexual Health in Question

January 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

SADDLE BROOK, N.J., Jan. 6, 2011 /- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the...


Weight-loss surgery improved female urinary problems but male erection issues got worse

January 6, 2011 5:36 am | by EurekAlert | Comments

(Wiley-Blackwell) Women who underwent gastric band surgery to lose weight reported significant improvements in urinary function and quality of life after the operation. But men undergoing the procedure did not enjoy the same significant urinary function improvements as the women....


Tomatoes found to contain nutrient which prevents vascular diseases

January 6, 2011 5:35 am | by EurekAlert | Comments

(Wiley-Blackwell) They are the most widely produced fruit in the world and now scientists in Japan have discovered that tomatoes contain a nutrient which could tackle the onset of vascular diseases. The research, published in the journal Molecular Nutrition & Food Research, reveals...


Pro-Pharmaceuticals pulls in $3M from stock financings

January 6, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Newton biotechnology firm Pro-Pharmaceuticals Inc. has closed a $2.1 million private placement offering, in addition to taking in about $1 million from the exercise of common stock warrants.

Neuroptix nabs $4.6M financing

January 6, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Acton-based Neuroptix Corp. has sold $4.6 million of a planned $9.1 million offering of equity and option or warrant securities, according to a regulatory filing. The company is developing combined optical scanning devices and diagnostic agents for the early detection of Alzheimer's disease.

Echo Therapeutics calls on $5.5M in new funding

January 6, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Echo Therapeutics Inc., a medical technology company making a needle-free monitoring and drug delivery system, has taken in $5.5 million in a set of new financing deals led by its majority shareholder Platinum Montaur Life Sciences LLC.

Cardium to Present at OneMedForum San Francisco 2011 Conference

January 6, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 6, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced today that it is scheduled to present at the OneMedForum Finance Conference for Emerging Healthcare and Life Sciences Companies on Tuesday, January 11, 2011 at 3:00 p.m. (PT) at the Sir Francis Drake Hotel...


Solos Endoscopy, Inc. Trends toward Strong Continued Growth in 2011

January 6, 2011 4:35 am | by Bio-Medicine.Org | Comments

BOSTON, Jan. 6, 2011 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company looks towards continued growth in 2011 through new product development, new product sales and the completion of the requirements for its ISO 13485 quality management system (QMS)...


CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Jan. 6, 2011 /- A new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period for patients with one or more of four chronic diseases concludes that patients who take medications as doctors direct may save the health care system as much as...


Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

PLYMOUTH, Mich., Jan. 6, 2011 /- Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that it has initiated a Phase 2 clinical study for ETC-1002, the company's...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.